Saitama, Japan

Eriko Otani

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lotte Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eriko Otani. Retrieved from https://idiyas.com/inventor/eriko-otani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eriko Otani - Innovator in Sebum Secretion Inhibition

Introduction

Eriko Otani is an inventor based in Saitama-shi, Japan. He has made significant contributions to the field of cosmetic and health-related innovations. His research focuses on inhibiting sebum secretion, which is crucial for various skin conditions.

Latest Patent Applications

Eriko Otani's notable patent application is titled "Sebum Secretion-Blocking Composition, and Food or Beverage Containing Same." The objective of this application is to provide a composition that inhibits sebum secretion and a food or drink product utilizing this composition. Through extensive studies, Otani discovered that sebum secretion can be inhibited by orally ingesting a collagen peptide, specifically hydrolyzed collagen. His application presents an oral sebum secretion inhibiting composition that includes a collagen hydrolysate, along with a food or drink product that contains this innovative composition.

Conclusion

Eriko Otani's work in developing a sebum secretion-blocking composition highlights his commitment to advancing health and cosmetic solutions. His innovative approach using collagen peptides represents a significant step forward in this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…